Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics
June 13, 2024 10:16 ET
|
Spherix Global Insights
EXTON, PA, June 13, 2024 (GLOBE NEWSWIRE) -- Since 2021, the treatment options for systemic lupus erythematosus (SLE) and lupus nephritis (LN) have expanded with the approval of AstraZeneca’s...
Cutaneous Lupus Erythematosus (CLE) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034
March 25, 2024 19:43 ET
|
Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Cutaneous Lupus Erythematosus (CLE) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ...
DelveInsight Analyzes a Thriving Cutaneous Lupus Erythematosus Pipeline in the Coming Years as Key Pharma Companies Enter the Sphere
October 27, 2021 20:00 ET
|
DelveInsight Business Research LLP
Las Vegas, USA, Oct. 27, 2021 (GLOBE NEWSWIRE) -- DelveInsight Analyzes a Thriving Cutaneous Lupus Erythematosus Pipeline in the Coming Years as Key Pharma Companies Enter the Sphere The...
Zylö and Hoth Therapeutics Forge Partnership to Develop Endocannabinoid-Based Drug to Treat Lupus
August 22, 2019 09:00 ET
|
Zylö Therapeutics
Zylö’s xerogel-derived delivery platform to be used to topically deliver the drug candidate Greenville, SC, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Zylö Therapeutics, dedicated to bringing innovative...
Endocannabinoids Demonstrate Efficacy in Lupus Model
November 01, 2018 09:45 ET
|
Zylö Therapeutics
Zylö’s Nanopod™ Delivery Technology Plays Key Role GREENVILLE, SC, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Zylö Therapeutics, a life science innovator bringing affordable first-to-market therapies to...